Inventor · disambiguated record
Alexander Bukreyev
Also filed as: BUKREYEV ALEXANDER · BUKREYEV ALEXANDER A
11 granted patents·5 pending applications·139 citations·filing 1997–2024
88Inventor score
Top patents by PatentIndex Score
16 records- 0193US6699476B1Production of recombinant respiratory syncytial viruses expressing immune modulatory moleculesFiled 2000·Granted Mar 2, 2004·46 cites·78 claims
- 0288US7709007B2Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 2004·Granted May 4, 2010·18 cites·46 claims
- 0386US5993824AProduction of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 1997·Granted Nov 30, 1999·69 cites·17 claims
- 0481US10479825B2Antibody-mediated neutralization of Marburg virusUNIV VANDERBILT·Filed 2016·Granted Nov 19, 2019·2 cites·24 claims
- 0575US7465794B2Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory moleculesUS HEALTH·Filed 2004·Granted Dec 16, 2008·4 cites·63 claims
- 0668US11084869B2Antibody-mediated neutralization of Marburg virusUNIV VANDERBILT·Filed 2019·Granted Aug 10, 2021·0 cites·19 claims
- 0767US2024325383A1Small Molecule Targeting of BRD4 for Treatment of COVID-19UNIV TEXAS·Filed 2024·Application pending·0 cites
- 0866US2021324051A1Antibody-mediated neutralization of marburg virusUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 0962US11054423B2Antibody-mediated neutralization of ebolavirusesUNIV VANDERBILT·Filed 2020·Granted Jul 6, 2021·0 cites·12 claims
- 1062US2025064919A1A SARS-COV-2 Human Parainfluenza Virus Type 3-Vectored VaccineUNIV TEXAS·Filed 2023·Application pending·0 cites
- 1160US11939370B2Pan-ebola virus neutralizing human antibodies and methods of use thereforUNIV VANDERBILT·Filed 2019·Granted Mar 26, 2024·0 cites·15 claims
- 1258US2025127870A1mRNA Vaccines Against HantavirusUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1353US10620204B2Antibody-mediated neutralization of Ebola virusesUNIV VANDERBILT·Filed 2016·Granted Apr 14, 2020·0 cites·11 claims
- 1450US11185554B2Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg diseaseEISAI R&D MAN CO LTD·Filed 2017·Granted Nov 30, 2021·0 cites·16 claims
- 1547US2005220767A1Production of recombinant respiratory syncytial viruses expressing immune modulatory moleculesCOLLINS PETER L·Filed 2004·Application pending·0 cites
- 1636US9447047B2Inhibitors of protein phosphatase-1 and uses thereofNEKHAI SERGEI·Filed 2013·Granted Sep 20, 2016·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →